Nucleome Therapeutics
Nucleome is a pre-clinical biotech company using cutting-edge 3D genome sequencing and AI to find genetic drivers of disease, and design drugs against them.
- What
- Life Sciences
- When
- Aug 2019
- CEO
- Mark Bodmer
- Status
- Private
- Investment
- Active
- OSE Board Director
- Jon Hepple